Comparing Isocitrate Dehydrogenase Inhibitors with Procarbazine, Lomustine, and Vincristine Chemotherapy for Oligodendrogliomas. [PDF]
Duran G +13 more
europepmc +1 more source
Corrigendum to: Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas. [PDF]
europepmc +1 more source
Targeting of Mutant Isocitrate Dehydrogenase in Glioma: A Systematic Review. [PDF]
Lanman TA, Gonzalez Castro LN.
europepmc +1 more source
Management of Adult Patients With Isocitrate Dehydrogenase-Mutant Gliomas in Australia: An Expert Position Statement From the Cooperative Trials Group for Neuro-Oncology. [PDF]
Pinkham MB +7 more
europepmc +1 more source
3D spatial sampling to quantify morphologic heterogeneity in isocitrate dehydrogenase-wildtype glioblastoma. [PDF]
Voong V +13 more
europepmc +1 more source
Corrigendum to: The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma. [PDF]
europepmc +1 more source
Treatment of Isocitrate Dehydrogenase-Mutant Gliomas. [PDF]
Chernet S +4 more
europepmc +1 more source
Poor diagnostic value of isocitrate dehydrogenase 1 R132H immunohistochemistry for determination of isocitrate dehydrogenase 1 status in patients with glioblastoma. [PDF]
Faried A, Hadi EJ, Agustina H.
europepmc +1 more source
Matching-Adjusted Indirect Comparison of Olutasidenib and Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Relapsed/Refractory Acute Myeloid Leukemia. [PDF]
Watts JM +9 more
europepmc +1 more source

